JP Stock MarketDetailed Quotes

4503 Astellas Pharma

Watchlist
  • 1715.5
  • +20.0+1.18%
20min DelayMarket Closed Aug 16 15:00 JST
3.10TMarket Cap181.15P/E (Static)

Astellas Pharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Astellas Pharma Q1 2025 Earnings Date

Currency：JPYAug 1, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
411.42B
473.12B
+61.71B
Beat Est.
+9.71%
+26.17%
+15.00%
EPS
--
20.94
--
+13.68%
Analyst Rating
Buy

Aug 16, 2024

Astellas Pharma Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 6 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q3-- / 448.171B--
--2025/Q2-- / 424.605B--
Aug 1, 20242025/Q1473.124B / 411.415B--
Apr 25, 20242024/Q4414.602B / 381.093B--
Feb 5, 20242024/Q3421.932B / 385.383B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q3-- / 448.171B--
--2025/Q2-- / 424.605B--
Aug 1, 20242025/Q1473.124B / 411.415B--
Apr 25, 20242024/Q4414.602B / 381.093B--
Feb 5, 20242024/Q3421.932B / 385.383B--

Unlock Free Earnings Estimates

Astellas Pharma Earnings Reports

  • Astellas Pharma: Earnings conference materials for Q1 of the fiscal year ending March 2025.

    Aug 1 02:00 ET

  • Astellas Pharma: Supplemental materials for the first quarter financial statements of March 2025.

    Aug 1 02:00 ET

  • Astellas Pharma: March 2025 first quarter financial results announcement [IFRS] (consolidated)

    Aug 1 02:00 ET

  • Astellas Pharma: Extraordinary Report

    Jul 1 01:47 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Aug 16, 2024

    Buy

    • Strong Buy

      37.50%

    • Buy

      12.50%

    • Hold

      43.75%

    • Underperform

      6.25%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    JP
    Overall
    Symbol
    Latest Price
    % Chg